Literature DB >> 20103781

NFAT pulls the strings during CD4+ T helper cell effector functions.

Natascha Hermann-Kleiter1, Gottfried Baier.   

Abstract

The Ca(2+) dependent transcription factor family known as nuclear factor of activated T cells (NFAT) has been shown to be important in T-cell immune responses. Because NFAT proteins have a weak DNA-binding capacity, they cooperate with other transcription factors at composite sites within the promoters of target genes. Recently, NFAT was shown to also be important for the induction of specific genetic programs that guide the differentiation and effector or regulatory activities of CD4(+) T helper subsets via the transcriptional regulation of their lineage-specific transcription factors, specifically T-bet (Th1), Gata3 (Th2), RORgammat (Th17), and Foxp3 (iTregs). In addition, the NFAT family governs the transcription of several signature cytokines, including their cytokine receptors. Subsequently, the integration of these complex intracellular signal transduction cascades is considered to critically determine the crosstalk between the T-cell receptor and receptors that are activated by both the adaptive and innate immune systems to determine pathways of T helper cell differentiation and function. Here, we carefully review the critical role of the established transcriptional partners and functional outcomes of these NFAT interactions in regard to the effector responses of these clinically relevant CD4(+) T helper subsets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103781     DOI: 10.1182/blood-2009-10-233585

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  86 in total

Review 1.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 2.  PharmGKB summary: cyclosporine and tacrolimus pathways.

Authors:  Julia M Barbarino; Christine E Staatz; Raman Venkataramanan; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2013-10       Impact factor: 2.089

3.  IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors.

Authors:  Gavin Whitehouse; Elizabeth Gray; Sotiris Mastoridis; Elliot Merritt; Elisavet Kodela; Jennie H M Yang; Richard Danger; Marta Mairal; Sofia Christakoudi; Juan J Lozano; Iain C Macdougall; Timothy I M Tree; Alberto Sanchez-Fueyo; Marc Martinez-Llordella
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

4.  Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation.

Authors:  Arijita Jash; Anupama Sahoo; Gi-Cheon Kim; Chang-Suk Chae; Ji-Sun Hwang; Jung-Eun Kim; Sin-Hyeog Im
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

5.  Cyclosporine-resistant, Rab27a-independent mobilization of intracellular preformed CD40 ligand mediates antigen-specific T cell help in vitro.

Authors:  Yoshinobu Koguchi; Jennifer L Gardell; Timothy J Thauland; David C Parker
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

6.  Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis.

Authors:  Wen-I Yeh; Ian L McWilliams; Laurie E Harrington
Journal:  J Immunol       Date:  2011-10-07       Impact factor: 5.422

7.  Excitatory pathway engaging glutamate, calcineurin, and NFAT upregulates IL-4 in ischemic neurons to polarize microglia.

Authors:  Shun-Ming Ting; Xiurong Zhao; Xueping Zheng; Jaroslaw Aronowski
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-19       Impact factor: 6.200

8.  Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.

Authors:  Christian H Gabriel; Fridolin Gross; Martin Karl; Heike Stephanowitz; Anna Floriane Hennig; Melanie Weber; Stefanie Gryzik; Ivo Bachmann; Katharina Hecklau; Jürgen Wienands; Johannes Schuchhardt; Hanspeter Herzel; Andreas Radbruch; Eberhard Krause; Ria Baumgrass
Journal:  J Biol Chem       Date:  2016-09-16       Impact factor: 5.157

9.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.

Authors:  Daniela F Quail; Robert L Bowman; Leila Akkari; Marsha L Quick; Alberto J Schuhmacher; Jason T Huse; Eric C Holland; James C Sutton; Johanna A Joyce
Journal:  Science       Date:  2016-05-20       Impact factor: 47.728

10.  Virus-specific CD4 and CD8 T cell responses in the absence of Th1-associated transcription factors.

Authors:  Sarah B Mollo; Jennifer T Ingram; Robert L Kress; Allan J Zajac; Laurie E Harrington
Journal:  J Leukoc Biol       Date:  2013-11-14       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.